<DOC>
	<DOCNO>NCT01714557</DOCNO>
	<brief_summary>Neutropenia common patient receive hematopoietic stem cell transplantation , median duration 14 day . Almost neutropenia suffer febrile without prophylactic antibiotic . IDSA recommend fluoroquinolones prophylaxis neutropenia patient high risk , China , major pathogen possess high resistance fluoroquinolones . It clear whether prophylaxis benefit , appropriate prophylaxis regimen . The current study evaluate three different regimen : 1 . No prophylaxic antibiotic 2 . Piperacillin prophylaxis neutropenia patient . Piperacillin anti-pseudomonas activity . 3 . Piperacillin/tazobactam prophylaxis neutropenia patient . Piperacillin/tazobactam high susceptibility rate among common anti-pseudomonas antibiotic .</brief_summary>
	<brief_title>Prophylactic Piperacillin/Tazobactam Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>1 . Swab culture ( skin , pharyngeal , nasal , anus ) administer laminar flow room transplantation . 2 . Randomize neutropenia patient 3 group . 3 . Receive 3 regimen . 4 . Full record clinical data , include background disease , previous antibiotic within 90 day , febrile TOC . 5 . For patient develop febrile , imipenem prescribed , even patient receive prophylaxis . At time , follow-up end .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<criteria>Age 1365 year Received Autologous Allogeneic hematopoietic stem cell transplantation . ECOG score 01 . ICF available . Allergic therapy drug . Documented infection neutropenia . Renal dysfunction . Suffering central nervous system mental disease .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>